Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)

Long‐Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension)

ABSTRACT The aim of the open label extension (OLE) of CTREPH study was to characterize multimodal treatment in patients with severe inoperable CTEPH, to describe long‐term subcutaneous (SC) treprostinil safety and tolerability, and to evaluate change in functional class and exercise capacity over 24...

Full description

Saved in:
Bibliographic Details
Main Authors: Pavel Jansa, Roela Sadushi‐Kolici, Nika Skoro‐Sajer, Grzegorz Kopec, Iveta Simkova, Regina Steringer‐Mascherbauer, Barbara Salobir, Jaroslav Lindner, Irene M. Lang
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Pulmonary Circulation
Subjects:
chronic thromboembolic pulmonary hypertension
multimodal treatment
subcutaneous treprostinil
Online Access:https://doi.org/10.1002/pul2.70080
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items